Table of Contents Author Guidelines Submit a Manuscript
Journal of Pregnancy
Volume 2012 (2012), Article ID 839656, 15 pages
http://dx.doi.org/10.1155/2012/839656
Review Article

Antenatal Steroids and the IUGR Fetus: Are Exposure and Physiological Effects on the Lung and Cardiovascular System the Same as in Normally Grown Fetuses?

1Early Origins of Adult Health Research Group, School of Pharmacy and Medical Sciences, Sansom Institute for Health Research, University of South Australia, GPO Box 2471, Adelaide, SA 5001, Australia
2Molecular and Evolutionary Physiology of the Lung Laboratory, School of Pharmacy and Medical Sciences, Sansom Institute for Health Research, University of South Australia, GPO Box 2471, Adelaide, SA 5001, Australia

Received 2 April 2012; Accepted 6 September 2012

Academic Editor: Timothy Regnault

Copyright © 2012 Janna L. Morrison et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. J. M. Moss, “Respiratory consequences of preterm birth,” Clinical and Experimental Pharmacology and Physiology, vol. 33, no. 3, pp. 280–284, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. P. J. Laws and E. A. Sullivan, “Australia's Mothers and Babies 2002,” PERINATAL STATISTICS SERIES, no. AIHW cat. no. PER 28, pp. 1–93, 2004.
  3. J. R. G. Challis, D. Sloboda, S. G. Matthews et al., “The fetal placental hypothalamic-pituitary-adrenal (HPA) axis, parturition and post natal health,” Molecular and Cellular Endocrinology, vol. 185, no. 1-2, pp. 135–144, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. I. C. McMillen and J. S. Robinson, “Developmental origins of the metabolic syndrome: prediction, plasticity, and programming,” Physiological Reviews, vol. 85, no. 2, pp. 571–633, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. J. L. Morrison, “Sheep models of intrauterine growth restriction: fetal adaptations and consequences,” Clinical and Experimental Pharmacology and Physiology, vol. 35, no. 7, pp. 730–743, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. W. M. Gilbert and B. Danielsen, “Pregnancy outcomes associated with intrauterine growth restriction,” American Journal of Obstetrics & Gynecology, vol. 188, no. 6, pp. 1596–9601, 2003. View at Google Scholar
  7. R. J. Hodges and E. M. Wallace, “Mending a growth-restricted fetal heart: should we use glucocorticoids?” Journal of Maternal-Fetal and Neonatal Medicine, vol. 25, no. 11, pp. 2149–2153, 2012. View at Google Scholar
  8. E. B. St. John, K. G. Nelson, S. P. Cliver, R. R. Bishnoi, and R. L. Goldenberg, “Cost of neonatal care according to gestational age at birth and survival status,” American Journal of Obstetrics and Gynecology, vol. 182, no. 1, part 1, pp. 170–175, 2000. View at Google Scholar · View at Scopus
  9. W. M. Gilbert, T. S. Nesbitt, and B. Danielsen, “The cost of prematurity: quantification by gestational age and birth weight,” Obstetrics and Gynecology, vol. 102, no. 3, pp. 488–492, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Polyakov, S. Cohen, M. Baum, D. Trickey, D. Jolley, and E. M. Wallace, “Patterns of antenatal corticosteroid prescribing 1998–2004,” Australian and New Zealand Journal of Obstetrics and Gynaecology, vol. 47, no. 1, pp. 42–45, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Ikegami, D. H. Polk, A. H. Jobe et al., “Effect of interval from fetal corticosteroid treatment to delivery on postnatal lung function of preterm lambs,” Journal of Applied Physiology, vol. 80, no. 2, pp. 591–597, 1996. View at Google Scholar · View at Scopus
  12. P. L. Ballard, Y. Ning, D. Polk, M. Ikegami, and A. H. Jobe, “Glucocorticoid regulation of surfactant components in immature lambs,” American Journal of Physiology, vol. 273, no. 5, part 1, pp. L1048–L1057, 1997. View at Google Scholar · View at Scopus
  13. A. H. Jobe and M. Ikegami, “Lung development and function in preterm infants in the surfactant treatment era,” Annual Review of Physiology, vol. 62, no. 1, pp. 825–846, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Roberts and S. Dalziel, “Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth,” Cochrane Database of Systematic Reviews, no. 3, Article ID CD004454, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. G. C. Liggins and R. N. Howie, “A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants,” Pediatrics, vol. 50, no. 4, pp. 515–525, 1972. View at Google Scholar · View at Scopus
  16. P. A. Crowley, “Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972 to 1994,” American Journal of Obstetrics and Gynecology, vol. 173, no. 1, pp. 322–335, 1995. View at Publisher · View at Google Scholar · View at Scopus
  17. C. A. Crowther, R. R. Haslam, J. E. Hiller, L. W. Doyle, and J. S. Robinson, “Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomised controlled trial,” The Lancet, vol. 367, no. 9526, pp. 1913–1919, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. T. J. Garite, J. Kurtzman, K. Maurel, and R. Clark, “Impact of a “rescue course” of antenatal corticosteroids: a multicenter randomized placebo-controlled trial,” American Journal of Obstetrics and Gynecology, vol. 200, no. 3, pp. 248.e1–248.e9, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. J. P. Newnham and A. H. Jobe, “Should we be prescribing repeated courses of antenatal corticosteroids?” Seminars in Fetal & Neonatal Medicine, vol. 14, no. 3, pp. 157–163, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. J. A. Quinlivan, S. F. Evans, S. A. Dunlop, L. D. Beazley, and J. P. Newnham, “Use of corticosteroids by Australian obstetricians—a survey of clinical practice,” Australian and New Zealand Journal of Obstetrics and Gynaecology, vol. 38, no. 1, pp. 1–7, 1998. View at Google Scholar · View at Scopus
  21. P. Brocklehurst, S. Gates, K. McKenzie-McHarg, Z. Alfirevic, and G. Chamberlain, “Are we prescribing multiple courses of antenatal corticosteroids? A survey of practice in the UK,” British Journal of Obstetrics and Gynaecology, vol. 106, no. 9, pp. 977–979, 1999. View at Google Scholar · View at Scopus
  22. L. C. Gilstrap, “Antenatal corticosteroids revisited: repeat courses—National Institutes of Health Consensus Development Conference Statement, August 17-18, 2000,” Obstetrics and Gynecology, vol. 98, no. 1, pp. 144–150, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Roberts and S. Dalziel, “Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth,” Cochrane Database of Systematic Reviews, vol. 3, Article ID CD004454, 2006. View at Google Scholar · View at Scopus
  24. S. Abbasi, D. Hirsch, J. Davis et al., “Effect of single versus multiple courses of antenatal corticosteroids on maternal and neonatal outcome,” American Journal of Obstetrics and Gynecology, vol. 182, no. 5, pp. 1243–1249, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. N. P. French, R. Hagan, S. F. Evans, M. Godfrey, and J. P. Newnham, “Repeated antenatal corticosteroids: size at birth and subsequent development,” American Journal of Obstetrics and Gynecology, vol. 180, no. 1, pp. 114–121, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. L. Pratt, R. R. Magness, T. Phernetton, S. K. Hendricks, D. H. Abbott, and I. M. Bird, “Repeated use of betamethasone in rabbits: effects of treatment variation on adrenal suppression, pulmonary maturation, and pregnancy outcome,” American Journal of Obstetrics and Gynecology, vol. 180, no. 4, pp. 995–1005, 1999. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Ikegami, A. H. Jobe, J. Newnham, D. H. Polk, K. E. Willet, and P. Sly, “Repetitive prenatal glucocorticoids improve lung function and decrease growth in preterm lambs,” American Journal of Respiratory and Critical Care Medicine, vol. 156, no. 1, pp. 178–184, 1997. View at Google Scholar · View at Scopus
  28. S. A. Dunlop, M. A. Archer, J. A. Quinlivan, L. D. Beazley, and J. P. Newnham, “Repeated prenatal corticosteroids delay myelination in the ovine Central Nervous System,” Journal of Maternal-Fetal and Neonatal Medicine, vol. 6, no. 6, pp. 309–313, 1997. View at Google Scholar · View at Scopus
  29. W. L. Huang, L. D. Beazley, J. A. Quinlivan, S. F. Evans, J. P. Newnham, and S. A. Dunlop, “Effect of corticosteroids on brain growth in fetal sheep,” Obstetrics and Gynecology, vol. 94, no. 2, pp. 213–218, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. J. P. Empana, M. M. Anceschi, I. Szabo, E. V. Cosmi, G. Breart, and P. Truffert, “Antenatal corticosteroids policies in 14 European countries: factors associated with multiple courses. The EURAIL survey,” Acta Paediatrica, vol. 93, no. 10, pp. 1318–1322, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. C. J. D. McKinlay, C. A. Crowther, P. Middleton, and J. E. Harding, “Repeat antenatal glucocorticoids for women at risk of preterm birth: a cochrane systematic review,” American Journal of Obstetrics and Gynecology, vol. 206, no. 3, pp. 187–194, 2012. View at Google Scholar
  32. C. A. Crowther, C. J. D. McKinlay, P. Middleton, and J. E. Harding, “Repeat doses of prenatal corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease,” Cochrane Database of Systematic Reviews, no. 6, Article ID CD003935, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. J. L. Morrison and S. Orgeig, “Review: antenatal glucocorticoid treatment of the growth-restricted fetus: benefit or cost?” Reproductive Sciences, vol. 16, no. 6, pp. 527–538, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. H. J. Schroder, “Models of fetal growth restriction,” European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 110, supplement 1, pp. S29–S39, 2003. View at Google Scholar
  35. G. Ghosh, A. Breborowicz, M. Brazert et al., “Evaluation of third trimester uterine artery flow velocity indices in relationship to perinatal complications,” Journal of Maternal-Fetal and Neonatal Medicine, vol. 19, no. 9, pp. 551–555, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Orgeig and J. L. Morrison, “Does the intrauterine growth-restricted fetus benefit from antenatal glucocorticoids?” Expert Review of Obstetrics and Gynecology, vol. 5, no. 2, pp. 149–152, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. I. M. Bernstein, J. D. Horbar, G. J. Badger, A. Ohlsson, and A. Golan, “Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction,” American Journal of Obstetrics and Gynecology, vol. 182, no. 1, part 1, pp. 198–206, 2000. View at Google Scholar · View at Scopus
  38. T. J. M. Moss, R. Harding, and J. P. Newnham, “Lung function, arterial pressure and growth in sheep during early postnatal life following single and repeated prenatal corticosteroid treatments,” Early Human Development, vol. 66, no. 1, pp. 11–24, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. S. L. Miller, M. Chai, J. Loose et al., “The effects of maternal betamethasone administration on the intrauterine growth-restricted fetus,” Endocrinology, vol. 148, no. 3, pp. 1288–1295, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. M. J. Simchen, F. Alkazaleh, S. L. Adamson et al., “The fetal cardiovascular response to antenatal steroids in severe early-onset intrauterine growth restriction,” American Journal of Obstetrics and Gynecology, vol. 190, no. 2, pp. 296–304, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. H. L. Torrance, J. B. Derks, S. A. Scherjon, L. D. Wijnberger, and G. H. A. Visser, “Is antenatal steroid treatment effective in preterm IUGR fetuses?” Acta Obstetricia et Gynecologica Scandinavica, vol. 88, no. 10, pp. 1068–1073, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. R. Wapner and A. H. Jobe, “Controversy: antenatal steroids,” Clinics in Perinatology, vol. 38, no. 3, pp. 529–545, 2011. View at Google Scholar
  43. T. L. Gross, R. J. Sokol, M. V. Wilson, P. M. Kuhnert, and V. Hirsch, “Amniotic fluid phosphatidylglycerol: a potentially useful predictor of intrauterine growth retardation,” American Journal of Obstetrics & Gynecology, vol. 140, no. 3, pp. 277–281, 1981. View at Google Scholar · View at Scopus
  44. D. L. Economides, K. H. Nicolaides, E. A. Linton, L. A. Perry, and T. Chard, “Plasma cortisol and adrenocorticotropin in appropriate and small for gestational age fetuses,” Fetal Therapy, vol. 3, no. 3, pp. 158–164, 1988. View at Google Scholar · View at Scopus
  45. J. E. Tyson, K. Kennedy, S. Broyles, and C. R. Rosenfeld, “The small for gestational age infant: accelerated or delayed pulmonary maturation? Increased or decreased survival?” Pediatrics, vol. 95, no. 4, pp. 534–538, 1995. View at Google Scholar · View at Scopus
  46. H. L. Torrance, E. J. H. Mulder, H. A. A. Brouwers, F. van Bel, and G. H. A. Visser, “Respiratory outcome in preterm small for gestational age fetuses with or without abnormal umbilical artery Doppler and/or maternal hypertension,” Journal of Maternal-Fetal and Neonatal Medicine, vol. 20, no. 8, pp. 613–621, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. D. D. Mcintire, S. L. Bloom, B. M. Casey, and K. J. Leveno, “Birth weight in relation to morbidity and mortality among newborn infants,” The New England Journal of Medicine, vol. 340, no. 16, pp. 1234–1238, 1999. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Elimian, U. Verma, J. Canterino, J. Shah, P. Visintainer, and N. Tejani, “Effectiveness of antenatal steroids in obstetric subgroups,” Obstetrics and Gynecology, vol. 93, no. 2, pp. 174–179, 1999. View at Publisher · View at Google Scholar · View at Scopus
  49. M. G. Gnanalingham, A. Mostyn, D. S. Gardner, T. Stephenson, and M. E. Symonds, “Developmental regulation of the lung in preparation for life after birth: hormonal and nutritional manipulation of local glucocorticoid action and uncoupling protein-2,” Journal of Endocrinology, vol. 188, no. 3, pp. 375–386, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. H. M. Reichardt and G. Schütz, “Glucocorticoid signalling—multiple variations of a common theme,” Molecular and Cellular Endocrinology, vol. 146, no. 1-2, pp. 1–6, 1998. View at Publisher · View at Google Scholar · View at Scopus
  51. A. L. Fowden, J. Li, and A. J. Forhead, “Glucocorticoids and the preparation for life after birth: are there long-term consequences of the life insurance?” Proceedings of the Nutrition Society, vol. 57, no. 1, pp. 113–122, 1998. View at Google Scholar · View at Scopus
  52. G. C. Liggins, “The role of cortisol in preparing the fetus for birth,” Reproduction, Fertility and Development, vol. 6, no. 2, pp. 141–150, 1994. View at Google Scholar · View at Scopus
  53. A. H. Jobe and R. F. Soll, “Choice and dose of corticosteroid for antenatal treatments,” American Journal of Obstetrics & Gynecology, vol. 190, no. 4, pp. 878–881, 2004. View at Publisher · View at Google Scholar · View at Scopus
  54. A. M. Nuyt, “Mechanisms underlying developmental programming of elevated blood pressure and vascular dysfunction: evidence from human studies and experimental animal models,” Clinical Science, vol. 114, no. 1-2, pp. 1–17, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. A. H. Jobe, J. P. Newnham, T. J. Moss, and M. Ikegami, “Differential effects of maternal betamethasone and cortisol on lung maturation and growth in fetal sheep,” American Journal of Obstetrics & Gynecology, vol. 188, no. 1, pp. 22–28, 2003. View at Publisher · View at Google Scholar · View at Scopus
  56. E. C. Jensen, B. W. Gallaher, B. H. Breier, and J. E. Harding, “The effect of a chronic maternal cortisol infusion on the late-gestation fetal sheep,” Journal of Endocrinology, vol. 174, no. 1, pp. 27–36, 2002. View at Publisher · View at Google Scholar · View at Scopus
  57. D. M. Sloboda, J. P. Newnham, and J. R. G. Challis, “Effects of repeated maternal betamethasone administration on growth and hypothalamic-pituitary-adrenal function of the ovine fetus at term,” Journal of Endocrinology, vol. 165, no. 1, pp. 79–91, 2000. View at Google Scholar · View at Scopus
  58. A. H. Jobe, N. Wada, L. M. Berry, M. Ikegami, and M. G. Ervin, “Single and repetitive maternal glucocorticoid exposures reduce fetal growth in sheep,” American Journal of Obstetrics & Gynecology, vol. 178, no. 5, pp. 880–885, 1998. View at Publisher · View at Google Scholar · View at Scopus
  59. L. S. Kerzner, B. S. Stonestreet, K. Y. Wu, G. Sadowska, and M. P. Malee, “Antenatal dexamethasone: effect on ovine placental 11β-hydroxysteroid dehydrogenase type 2 expression and fetal growth,” Pediatric Research, vol. 52, no. 5, pp. 706–712, 2002. View at Publisher · View at Google Scholar · View at Scopus
  60. D. M. Sloboda, T. J. Moss, L. C. Gurrin, J. P. Newnham, and J. R. G. Challis, “The effect of prenatal betamethasone administration on postnatal ovine hypothalamic-pituitary-adrenal function,” Journal of Endocrinology, vol. 172, no. 1, pp. 71–81, 2002. View at Publisher · View at Google Scholar · View at Scopus
  61. J. B. Derks, D. A. Giussani, S. L. Jenkins et al., “A comparative study of cardiovascular, endocrine and behavioural effects of betamethasone and dexamethasone administration to fetal sheep,” Journal of Physiology, vol. 499, no. 1, pp. 217–226, 1997. View at Google Scholar · View at Scopus
  62. S. A. Dunlop, M. A. Archer, J. A. Quinlivan, L. D. Beazley, and J. P. Newnham, “Repeated prenatal corticosteroids delay myelination in the ovine Central Nervous System,” Journal of Maternal-Fetal and Neonatal Medicine, vol. 6, no. 6, pp. 309–313, 1997. View at Google Scholar · View at Scopus
  63. I. Antonow-Schlorke, T. Müller, M. Brodhun et al., “Betamethasone-related acute alterations of microtubule-associated proteins in the fetal sheep brain are reversible and independent of age during the last one-third of gestation,” American Journal of Obstetrics & Gynecology, vol. 196, no. 6, pp. 553.e1–553.e6, 2007. View at Publisher · View at Google Scholar · View at Scopus
  64. W. L. Huang, L. D. Beazley, J. A. Quinlivan, S. F. Evans, J. P. Newnham, and S. A. Dunlop, “Effect of corticosteroids on brain growth in fetal sheep,” Obstetrics and Gynecology, vol. 94, no. 2, pp. 213–218, 1999. View at Publisher · View at Google Scholar · View at Scopus
  65. W. L. Huang, C. G. Harper, S. F. Evans, J. P. Newnham, and S. A. Dunlop, “Repeated prenatal corticosteroid administration delays myelination of the corpus callosum in fetal sheep,” International Journal of Developmental Neuroscience, vol. 19, no. 4, pp. 415–425, 2001. View at Publisher · View at Google Scholar · View at Scopus
  66. J. McCallum, N. Smith, J. N. MacLachlan et al., “Effects of antenatal glucocorticoids on cerebral protein synthesis in the preterm ovine fetus,” American Journal of Obstetrics & Gynecology, vol. 198, no. 1, pp. 103.e1–103.e6, 2008. View at Publisher · View at Google Scholar · View at Scopus
  67. B. S. Stonestreet, C. M. Elitt, J. Markowitz, K. H. Petersson, and G. B. Sadowska, “Effects of antenatal corticosteroids on regional brain and non-neural tissue water content in the ovine fetus,” Journal of the Society for Gynecologic Investigation, vol. 10, no. 2, pp. 59–66, 2003. View at Publisher · View at Google Scholar · View at Scopus
  68. W. L. Huang, C. G. Harper, S. F. Evans, J. P. Newnham, and S. A. Dunlop, “Repeated prenatal corticosteroid administration delays astrocyte and capillary tight junction maturation in fetal sheep,” International Journal of Developmental Neuroscience, vol. 19, no. 5, pp. 487–493, 2001. View at Publisher · View at Google Scholar · View at Scopus
  69. R. Benediktsson, A. A. Calder, C. R. W. Edwards, and J. R. Seckl, “Placental 11β-hydroxysteroid dehydrogenase: a key regulator of fetal glucocorticoid exposure,” Clinical Endocrinology, vol. 46, no. 2, pp. 161–166, 1997. View at Google Scholar · View at Scopus
  70. H. J. L. Speirs, J. R. Seckl, and R. W. Brown, “Ontogeny of glucocorticoid receptor and 11β-hydroxysteroid dehydrogenase type-1 gene expression identifies potential critical periods of glucocorticoid susceptibility during development,” Journal of Endocrinology, vol. 181, no. 1, pp. 105–116, 2004. View at Publisher · View at Google Scholar · View at Scopus
  71. J. R. Seckl, “11β-Hydroxysteroid dehydrogenase in the brain: a novel regulator of glucocorticoid action?” Frontiers in Neuroendocrinology, vol. 18, no. 1, pp. 49–99, 1997. View at Publisher · View at Google Scholar · View at Scopus
  72. Y. Kotelevtsev, M. C. Holmes, A. Burchell et al., “11β-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 26, pp. 14924–14929, 1997. View at Publisher · View at Google Scholar · View at Scopus
  73. A. K. Agarwal, C. Monder, B. Eckstein, and P. C. White, “Cloning and expression of rat cDNA encoding corticosteroid 11β-dehydrogenase,” The Journal of Biological Chemistry, vol. 264, no. 32, pp. 18939–18943, 1989. View at Google Scholar · View at Scopus
  74. R. W. Brown, R. Diaz, A. C. Robson et al., “The ontogeny of 11β-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor gene expression reveal intricate control of glucocorticoid action in development,” Endocrinology, vol. 137, no. 2, pp. 794–797, 1996. View at Publisher · View at Google Scholar · View at Scopus
  75. E. Schoof, M. Girstl, W. Frobenius et al., “Course of placental 11β-hydroxysteroid dehydrogenase type 2 and 15-hydroxyprostaglandin dehydrogenase mRNA expression during human gestation,” European Journal of Endocrinology, vol. 145, no. 2, pp. 187–192, 2001. View at Google Scholar · View at Scopus
  76. R. Sampath-Kumar, S. G. Matthews, and K. Yang, “11β-Hydroxysteroid dehydrogenase type 2 is the predominant isozyme in the guinea pig placenta: decreases in messenger ribonucleic acid and activity at term,” Biology of Reproduction, vol. 59, no. 6, pp. 1378–1384, 1998. View at Google Scholar · View at Scopus
  77. K. Sun, K. Yang, and J. R. G. Challis, “Differential regulation of 11 β-hydroxysteroid dehydrogenase type 1 and 2 by nitric oxide in cultured human placental trophoblast and chorionic cell preparation,” Endocrinology, vol. 138, no. 11, pp. 4912–4920, 1997. View at Publisher · View at Google Scholar · View at Scopus
  78. B. E. Pearson Murphy, S. J. Clark, and I. R. Donald, “Conversion of maternal cortisol to cortisone during placental transfer to the human fetus,” American Journal of Obstetrics & Gynecology, vol. 118, no. 4, pp. 538–541, 1974. View at Google Scholar · View at Scopus
  79. K. A. Clarke, J. W. Ward, A. J. Forhead, D. A. Giussani, and A. L. Fowden, “Regulation of 11β-hydroxysteroid dehydrogenase type 2 activity in ovine placenta by fetal cortisol,” Journal of Endocrinology, vol. 172, no. 3, pp. 527–534, 2002. View at Publisher · View at Google Scholar · View at Scopus
  80. K. Yang, “Placental 11β-hydroxysteroid dehydrogenase: barrier to maternal glucocorticoids,” Reviews of Reproduction, vol. 2, no. 3, pp. 129–132, 1997. View at Publisher · View at Google Scholar · View at Scopus
  81. R. S. Lindsay, R. M. Lindsay, B. J. Waddell, and J. R. Seckl, “Prenatal glucocorticoid exposure leads to offspring hyperglycaemia in the rat: studies with the 11 β-hydroxysteroid dehydrogenase inhibitor carbenoxolone,” Diabetologia, vol. 39, no. 11, pp. 1299–1305, 1996. View at Publisher · View at Google Scholar · View at Scopus
  82. E. M. Leslie, R. G. Deeley, and S. P. C. Cole, “Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense,” Toxicology and Applied Pharmacology, vol. 204, no. 3, pp. 216–237, 2005. View at Publisher · View at Google Scholar · View at Scopus
  83. J. M. Croop, M. Raymond, D. Haber et al., “The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues,” Molecular and Cellular Biology, vol. 9, no. 3, pp. 1346–1350, 1989. View at Google Scholar · View at Scopus
  84. Y. Tanaka, A. L. Slitt, T. M. Leazer, J. M. Maher, and C. D. Klaassen, “Tissue distribution and hormonal regulation of the breast cancer resistance protein (Bcrp/Abcg2) in rats and mice,” Biochemical and Biophysical Research Communications, vol. 326, no. 1, pp. 181–187, 2004. View at Publisher · View at Google Scholar · View at Scopus
  85. M. Sun, J. Kingdom, D. Baczyk, S. J. Lye, S. G. Matthews, and W. Gibb, “Expression of the multidrug resistance P-glycoprotein, (ABCB1 glycoprotein) in the human placenta decreases with advancing gestation,” Placenta, vol. 27, no. 6-7, pp. 602–609, 2006. View at Publisher · View at Google Scholar · View at Scopus
  86. G. M. Kalabis, S. Petropoulos, W. Gibb, and S. G. Matthews, “Multidrug resistance phosphoglycoprotein (ABCB1) expression in the guinea pig placenta: developmental changes and regulation by betamethasone,” Canadian Journal of Physiology and Pharmacology, vol. 87, no. 11, pp. 973–978, 2009. View at Publisher · View at Google Scholar · View at Scopus
  87. G. R. Lankas, L. D. Wise, M. E. Cartwright, T. Pippert, and D. R. Umbenhauer, “Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice,” Reproductive Toxicology, vol. 12, no. 4, pp. 457–463, 1998. View at Publisher · View at Google Scholar · View at Scopus
  88. L. Zhou, S. B. Naraharisetti, H. Wang, J. D. Unadkat, M. F. Hebert, and Q. Mao, “The breast cancer resistance protein (Bcrp1/Abcg2) limits fetal distribution of glyburide in the pregnant mouse: An Obstetric-Fetal Pharmacology Research Unit Network and University of Washington Specialized Center of Research Study,” Molecular Pharmacology, vol. 73, no. 3, pp. 949–959, 2008. View at Publisher · View at Google Scholar · View at Scopus
  89. M. Uhr, F. Holsboer, and M. B. Müller, “Penetration of endogenous steroid hormones corticosterone, cortisol, aldosterone and progesterone into the brain is enhanced in mice deficient for both mdr1a and mdr1b P-glycoproteins,” Journal of Neuroendocrinology, vol. 14, no. 9, pp. 753–759, 2002. View at Publisher · View at Google Scholar · View at Scopus
  90. C. R. Yates, C. Chang, J. D. Kearbey et al., “Structural determinants of P-glycoprotein-mediated transport of glucocorticoids,” Pharmaceutical Research, vol. 20, no. 11, pp. 1794–1803, 2003. View at Publisher · View at Google Scholar · View at Scopus
  91. M. Iqbal, M. C. Audette, S. Petropoulos, W. Gibb, and S. G. Matthews, “Placental drug transporters and their role in fetal protection,” Placenta, vol. 33, no. 3, pp. 137–142, 2012. View at Google Scholar
  92. P. S. Soo, J. Hiscock, K. J. Botting, C. T. Roberts, A. K. Davey, and J. L. Morrison, “Maternal undernutrition reduces P-glycoprotein in guinea pig placenta and developing brain in late gestation,” Reproductive Toxicology, vol. 33, no. 3, pp. 374–381, 2012. View at Google Scholar
  93. C. Bertram, A. R. Trowern, N. Copin, A. A. Jackson, and C. B. Whorwood, “The maternal diet during pregnancy programs altered expression of the glucocorticoid receptor and type 2 11β-hydroxysteroid dehydrogenase: potential molecular mechanisms underlying the programming of hypertension in utero,” Endocrinology, vol. 142, no. 7, pp. 2841–2853, 2001. View at Publisher · View at Google Scholar · View at Scopus
  94. N. Alfaidy, S. Gupta, C. DeMarco, I. Caniggia, and J. R. G. Challis, “Oxygen regulation of placental 11β-hydroxysteroid dehydrogenase 2: physiological and pathological implications,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 10, pp. 4797–4805, 2002. View at Publisher · View at Google Scholar · View at Scopus
  95. L. D. Coles, I. J. Lee, H. E. Hassan, and N. D. Eddington, “Distribution of saquinavir, methadone, and buprenorphine in maternal brain, placenta, and fetus during two different gestational stages of pregnancy in mice,” Journal of Pharmaceutical Sciences, vol. 98, no. 8, pp. 2832–2846, 2009. View at Publisher · View at Google Scholar · View at Scopus
  96. S. Petropoulos, G. M. Kalabis, W. Gibb, and S. G. Matthews, “Functional changes of mouse placental multidrug resistance phosphoglycoprotein (ABCB1) with advancing gestation and regulation by progesterone,” Reproductive Sciences, vol. 14, no. 4, pp. 321–328, 2007. View at Publisher · View at Google Scholar · View at Scopus
  97. O. Dammann and S. G. Matthews, “Repeated antenatal glucocorticoid exposure and the developing brain,” Pediatric Research, vol. 50, no. 5, pp. 563–564, 2001. View at Google Scholar · View at Scopus
  98. M. Löhle, T. Müller, C. Wicher et al., “Betamethasone effects on fetal sheep cerebral blood flow are not dependent on maturation of cerebrovascular system and pituitary-adrenal axis,” Journal of Physiology, vol. 564, part 2, pp. 575–588, 2005. View at Publisher · View at Google Scholar · View at Scopus
  99. I. Antonow-Schlorke, M. Ebert, C. Li et al., “Lack of effect of antenatal glucocorticoid therapy in the fetal baboon on cerebral cortical glucose transporter proteins,” Journal of Medical Primatology, vol. 36, no. 1, pp. 17–20, 2007. View at Publisher · View at Google Scholar · View at Scopus
  100. I. Antonow-Schlorke, M. Ebert, T. Müller et al., “Glucose transporter proteins GLUT1 and GLUT3 like immunoreactivities in the fetal sheep brain are not reduced by maternal betamethasone treatment,” Neuroscience Letters, vol. 403, no. 3, pp. 261–265, 2006. View at Publisher · View at Google Scholar · View at Scopus
  101. B. S. Stonestreet, G. B. Sadowska, A. J. McKnight, C. Patlak, and K. H. Petersson, “Exogenous and endogenous corticosteroids modulate blood-brain barrier development in the ovine fetus,” American Journal of Physiology, vol. 279, no. 2, pp. R468–R477, 2000. View at Google Scholar · View at Scopus
  102. A. H. Schinkel, U. Mayer, E. Wagenaar et al., “Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 8, pp. 4028–4033, 1997. View at Publisher · View at Google Scholar · View at Scopus
  103. V. S. Narang, C. Fraga, N. Kumar et al., “Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier,” American Journal of Physiology, vol. 295, no. 2, pp. C440–C450, 2008. View at Publisher · View at Google Scholar · View at Scopus
  104. I. D. Phillips, G. Simonetta, J. A. Owens, J. S. Robinson, I. J. Clarke, and I. C. McMillen, “Placental restriction alters the functional development of the pituitary-adrenal axis in the sheep fetus during late gestation,” Pediatric Research, vol. 40, no. 6, pp. 861–866, 1996. View at Google Scholar · View at Scopus
  105. L. W. Doyle, G. W. Ford, N. M. Davis, and C. Callanan, “Antenatal corticosteroid therapy and blood pressure at 14 years of age in preterm children,” Clinical Science, vol. 98, no. 2, pp. 137–142, 2000. View at Google Scholar · View at Scopus
  106. S. L. Miller, V. G. Supramaniam, G. Jenkin, D. W. Walker, and E. M. Wallace, “Cardiovascular responses to maternal betamethasone administration in the intrauterine growth-restricted ovine fetus,” American Journal of Obstetrics & Gynecology, vol. 201, no. 6, pp. 613.e1–613.e8, 2009. View at Publisher · View at Google Scholar · View at Scopus
  107. J. B. Derks, D. A. Giussani, S. L. Jenkins et al., “A comparative study of cardiovascular, endocrine and behavioural effects of betamethasone and dexamethasone administration to fetal sheep,” Journal of Physiology, vol. 499, part 1, pp. 217–226, 1997. View at Google Scholar · View at Scopus
  108. L. Bennet, S. Kozuma, H. H. G. McGarrigle, and M. A. Hanson, “Temporal changes in fetal cardiovascular, behavioural, metabolic and endocrine responses to maternally administered dexamethasone in the late gestation fetal sheep,” British Journal of Obstetrics and Gynaecology, vol. 106, no. 4, pp. 331–339, 1999. View at Google Scholar · View at Scopus
  109. J. K. Jellyman, D. S. Gardner, C. M. B. Edwards, A. L. Fowden, and D. A. Giussani, “Fetal cardiovascular, metabolic and endocrine responses to acute hypoxaemia during and following maternal treatment with dexamethasone in sheep,” Journal of Physiology, vol. 567, part 2, pp. 673–688, 2005. View at Publisher · View at Google Scholar · View at Scopus
  110. I. C. McMillen, M. B. Adams, J. T. Ross et al., “Fetal growth restriction: adaptations and consequences,” Reproduction, vol. 122, no. 2, pp. 195–204, 2001. View at Google Scholar · View at Scopus
  111. J. Murotsuki, R. Gagnon, S. G. Matthews, and J. R. G. Challis, “Effects of long-term hypoxemia on pituitary-adrenal function in fetal sheep,” American Journal of Physiology, vol. 271, no. 4, part 1, pp. E678–E685, 1996. View at Google Scholar · View at Scopus
  112. S. Orgeig, J. L. Morrison, and C. B. Daniels, “Prenatal development of the pulmonary surfactant system and the influence of hypoxia,” Respiratory Physiology and Neurobiology, vol. 178, no. 1, pp. 129–145, 2011. View at Publisher · View at Google Scholar · View at Scopus
  113. I. D. Phillips, R. V. Anthony, G. Simonetta, J. A. Owens, J. S. Robinson, and I. C. McMillen, “Restriction of fetal growth has a differential impact on fetal prolactin and prolactin receptor mRNA expression,” Journal of Neuroendocrinology, vol. 13, no. 2, pp. 175–181, 2001. View at Publisher · View at Google Scholar · View at Scopus
  114. V. Boggaram, “Regulation of lung sufactant protein gene expression,” Frontiers in Bioscience, vol. 8, pp. d751–d767, 2003. View at Google Scholar · View at Scopus
  115. T. E. Weaver and J. A. Whitsett, “Function and regulation of expression of pulmonary surfactant-associated proteins,” Biochemical Journal, vol. 273, part 2, pp. 249–264, 1991. View at Google Scholar · View at Scopus
  116. J. L. Alcorn, K. N. Islam, P. P. Young, and C. R. Mendelson, “Glucocorticoid inhibition of SP-A gene expression in lung type II cells is mediated via the TTF-1-binding element,” American Journal of Physiology, vol. 286, no. 4, pp. L767–L776, 2004. View at Google Scholar · View at Scopus
  117. M. Yi, G. X. Tong, B. Murry, and C. R. Mendelson, “Role of CBP/p300 and SRC-1 in transcriptional regulation of the pulmonary surfactant protein-A (SP-A) gene by thyroid transcription factor-1 (TTF-1),” The Journal of Biological Chemistry, vol. 277, no. 4, pp. 2997–3005, 2002. View at Publisher · View at Google Scholar · View at Scopus
  118. V. Boggaram, “Thyroid transcription factor-I (TTF-I/Nkx2.I/TITFI) gene regulation in the lung,” Clinical Science, vol. 116, no. 1, pp. 27–35, 2009. View at Publisher · View at Google Scholar · View at Scopus
  119. M. T. Stahlman, M. E. Gray, and J. A. Whitsett, “Expression of thyroid transcription factor-1 (TTF-1) in fetal and neonatal human lung,” Journal of Histochemistry and Cytochemistry, vol. 44, no. 7, pp. 673–678, 1996. View at Google Scholar · View at Scopus
  120. M. D. Bruno, R. J. Bohinski, K. M. Huelsman, J. A. Whitsett, and T. R. Korfhagen, “Lung cell-specific expression of the murine surfactant protein A (SP-A) gene is mediated by interactions between the SP-A promoter and thyroid transcription factor-1,” The Journal of Biological Chemistry, vol. 270, no. 12, pp. 6531–6536, 1995. View at Publisher · View at Google Scholar · View at Scopus
  121. S. E. Kelly, C. J. Bachurski, M. S. Burhans, and S. W. Glasser, “Transcription of the lung-specific surfactant protein C gene is mediated by thyroid transcription factor 1,” The Journal of Biological Chemistry, vol. 271, no. 12, pp. 6881–6888, 1996. View at Publisher · View at Google Scholar · View at Scopus
  122. C. R. Mendelson, “Role of transcription factors in fetal lung development and surfactant protein gene expression,” Annual Review of Physiology, vol. 62, no. 1, pp. 875–915, 2000. View at Publisher · View at Google Scholar · View at Scopus
  123. V. Davé, T. Childs, and J. A. Whitsett, “Nuclear factor of activated T cells regulates transcription of the surfactant protein D gene (Sftpd) via direct interaction with thyroid transcription factor-1 in lung epithelial cells,” The Journal of Biological Chemistry, vol. 279, no. 33, pp. 34578–34588, 2004. View at Publisher · View at Google Scholar · View at Scopus
  124. A. Losada, J. A. Tovar, H. M. Xia, J. A. Diez-Pardo, and P. Santisteban, “Down-regulation of thyroid transcription factor-1 gene expression in fetal lung hypoplasia is restored by glucocorticoids,” Endocrinology, vol. 141, no. 6, pp. 2166–2173, 2000. View at Publisher · View at Google Scholar · View at Scopus
  125. R. J. Bohinski, R. Di Lauro, and J. A. Whitsett, “The lung-specific surfactant protein B gene promoter is a target for thyroid transcription factor 1 and hepatocyte nuclear factor 3, indicating common factors for organ-specific gene expression along the foregut axis,” Molecular and Cellular Biology, vol. 14, no. 9, pp. 5671–5681, 1994. View at Google Scholar · View at Scopus
  126. S. Orgeig, T. A. Crittenden, C. Marchant, I. C. McMillen, and J. L. Morrison, “Intrauterine growth restriction delays surfactant protein maturation in the sheep fetus,” American Journal of Physiology, vol. 298, no. 4, pp. L575–L583, 2010. View at Publisher · View at Google Scholar · View at Scopus
  127. R. Gagnon, J. Langridge, K. Inchley, J. Murotsuki, and F. Possmayer, “Changes in surfactant-associated protein mRNA profile in growth- restricted fetal sheep,” American Journal of Physiology, vol. 276, no. 3, part 1, pp. L459–L465, 1999. View at Google Scholar · View at Scopus
  128. M. L. Cock, C. A. Albuquerque, B. J. Joyce, S. B. Hooper, and R. Harding, “Effects of intrauterine growth restriction on lung liquid dynamics and lung development in fetal sheep,” American Journal of Obstetrics & Gynecology, vol. 184, no. 2, pp. 209–216, 2001. View at Publisher · View at Google Scholar · View at Scopus
  129. A. E. Sutherland, K. J. Crossley, B. J. Allison, G. Jenkin, E. M. Wallace, and S. L. Miller, “The effects of intrauterine growth restriction and antenatal glucocorticoids on ovine fetal lung development,” Pediatric Research, vol. 71, no. 6, pp. 689–696, 2012. View at Google Scholar
  130. D. L. Economides, K. H. Nicolaides, and S. Campbell, “Metabolic and endocrine findings in appropriate and small for gestational age fetuses,” Journal of Perinatal Medicine, vol. 19, no. 1-2, pp. 97–105, 1991. View at Google Scholar · View at Scopus
  131. L. Danielson, I. C. McMillen, J. L. Dyer, and J. L. Morrison, “Restriction of placental growth results in greater hypotensive response to α-adrenergic blockade in fetal sheep during late gestation,” Journal of Physiology, vol. 563, no. 2, pp. 611–620, 2005. View at Publisher · View at Google Scholar · View at Scopus
  132. M. G. Gnanalingham, A. Mostyn, J. Dandrea, D. P. Yakubu, M. E. Symonds, and T. Stephenson, “Ontogeny and nutritional programming of uncoupling protein-2 and glucocorticoid receptor mRNA in the ovine lung,” Journal of Physiology, vol. 565, part 1, pp. 159–169, 2005. View at Publisher · View at Google Scholar · View at Scopus
  133. M. G. Gnanalingham, D. A. Giussani, P. Sivathondan et al., “Chronic umbilical cord compression results in accelerated maturation of lung and brown adipose tissue in the sheep fetus during late gestation,” American Journal of Physiology, vol. 289, no. 3, pp. E456–E465, 2005. View at Publisher · View at Google Scholar · View at Scopus
  134. A. J. W. Fletcher, H. H. G. McGarrigle, C. M. B. Edwards, A. L. Fowden, and D. A. Giussani, “Effects of low dose dexamethasone treatment on basal cardiovascular and endocrine function in fetal sheep during late gestation,” Journal of Physiology, vol. 545, part 2, pp. 649–660, 2002. View at Publisher · View at Google Scholar · View at Scopus
  135. M. Schwab, M. Roedel, M. A. Anwar et al., “Effects of betamethasone administration to the fetal sheep in late gestation on fetal cerebral blood flow,” Journal of Physiology, vol. 528, no. 3, pp. 619–632, 2000. View at Google Scholar · View at Scopus
  136. A. J. Forhead, F. Broughton Pipkin, and A. L. Fowden, “Effect of cortisol on blood pressure and the renin-angiotensin system in fetal sheep during late gestation,” Journal of Physiology, vol. 526, part 1, pp. 167–176, 2000. View at Google Scholar · View at Scopus
  137. A. J. Forhead and A. L. Fowden, “Role of angiotensin II in the pressor response to cortisol in fetal sheep during late gestation,” Experimental Physiology, vol. 89, no. 3, pp. 323–329, 2004. View at Publisher · View at Google Scholar · View at Scopus
  138. K. Tangalakis, E. R. Lumbers, K. M. Moritz, M. K. Towstoless, and E. M. Wintour, “Effect of cortisol on blood pressure and vascular reactivity in the ovine fetus,” Experimental Physiology, vol. 77, no. 5, pp. 709–717, 1992. View at Google Scholar · View at Scopus
  139. L. F. J. Mildenhall, M. R. Battin, S. M. B. Morton, C. Bevan, C. A. Kuschel, and J. E. Harding, “Exposure to repeat doses of antenatal glucocorticoids is associated with altered cardiovascular status after birth,” Archives of Disease in Childhood, vol. 91, no. 1, pp. F56–F60, 2006. View at Publisher · View at Google Scholar · View at Scopus
  140. L. Danielson, I. C. McMillen, J. L. Dyer, and J. L. Morrison, “Restriction of placental growth results in greater hypotensive response to α-adrenergic blockade in fetal sheep during late gestation,” Journal of Physiology, vol. 563, part 2, pp. 611–620, 2005. View at Publisher · View at Google Scholar · View at Scopus
  141. L. J. Edwards, G. Simonetta, J. A. Owens, J. S. Robinson, and I. C. McMillen, “Restriction of placental and fetal growth in sheep alters fetal blood pressure responses to angiotensin II and captopril,” Journal of Physiology, vol. 515, part 3, pp. 897–904, 1999. View at Google Scholar · View at Scopus
  142. G. D. Giraud, S. Louey, S. Jonker, J. Schultz, and K. L. Thornburg, “Cortisol stimulates cell cycle activity in the cardiomyocyte of the sheep fetus,” Endocrinology, vol. 147, no. 8, pp. 3643–3649, 2006. View at Publisher · View at Google Scholar · View at Scopus
  143. A. M. Rudolph, C. Roman, and V. Gournay, “Perinatal myocardial DNA and protein changes in the lamb: effect of cortisol in the fetus,” Pediatric Research, vol. 46, no. 2, pp. 141–146, 1999. View at Google Scholar · View at Scopus
  144. S. S. Jonker, T. D. Scholz, and J. L. Segar, “The effect of adrenalectomy on the cardiac response to subacute fetal anemia,” Canadian Journal of Physiology and Pharmacology, vol. 89, no. 2, pp. 79–88, 2011. View at Publisher · View at Google Scholar · View at Scopus
  145. A. M. Rudolph, “Myocardial growth before and after birth: clinical implications,” Acta Paediatrica, vol. 89, no. 2, pp. 129–133, 2000. View at Google Scholar · View at Scopus
  146. S. Louey, S. S. Jonker, G. D. Giraud, and K. L. Thornburg, “Placental insufficiency decreases cell cycle activity and terminal maturation in fetal sheep cardiomyocytes,” Journal of Physiology, vol. 580, part 2, pp. 639–648, 2007. View at Publisher · View at Google Scholar · View at Scopus
  147. K. J. Bubb, M. L. Cock, M. J. Black et al., “Intrauterine growth restriction delays cardiomyocyte maturation and alters coronary artery function in the fetal sheep,” Journal of Physiology, vol. 578, part 3, pp. 871–881, 2007. View at Publisher · View at Google Scholar · View at Scopus
  148. J. L. Morrison, K. J. Botting, J. L. Dyer, S. J. Williams, K. L. Thornburg, and I. C. McMillen, “Restriction of placental function alters heart development in the sheep fetus,” American Journal of Physiology, vol. 293, no. 1, pp. R306–R313, 2007. View at Publisher · View at Google Scholar · View at Scopus
  149. S. Bae, Y. Xiao, G. Li, C. A. Casiano, and L. Zhang, “Effect of maternal chronic hypoxic exposure during gestation on apoptosis in fetal rat heart,” American Journal of Physiology, vol. 285, no. 3, pp. H983–H990, 2003. View at Google Scholar · View at Scopus
  150. K. C. Wang, L. Zhang, I. C. McMillen et al., “Fetal growth restriction and the programming of heart growth and cardiac insulin-like growth factor 2 expression in the lamb,” The Journal of Physiology, vol. 589, part 19, pp. 4709–4722, 2011. View at Google Scholar
  151. K. C. Wang, D. A. Brooks, K. J. Botting, and J. L. Morrison, “IGF-2R-mediated signaling results in hypertrophy of cultured cardiomyocytes from fetal sheep,” Biology of Reproduction, vol. 86, no. 6, p. 183, 2012. View at Google Scholar